trial

Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Schizophrenia Patients With Auditory Hallucinations

NCTId NCT02863094
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 60 (actual)
Sponsored by Anhui Medical University
Primary completion 2021-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
60 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2016-05
Primary completion
2021-08
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
Transcranial Magnetic Stimulation

Sponsors

Anhui Medical UniversityLead Sponsor

Investigators

1
Kai Wang, MDPrincipal Investigator

Sites

1 total
Hefei, China

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2021-08
Status
COMPLETED
relationships
The graph out of here
drug
Transcranial Magnetic Stimulation
drug
lead_sponsor
Anhui Medical University
company
indication
Hallucinations
indication
Functional Magnetic Resonance Imaging
indication
Schizophrenia
indication
investigator
Kai Wang, MD
person